Novacyt S.A. (NVYTF)
Market Cap | 47.64M |
Revenue (ttm) | 23.46M |
Net Income (ttm) | -47.57M |
Shares Out | n/a |
EPS (ttm) | -0.67 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 200 |
Open | 0.566 |
Previous Close | n/a |
Day's Range | 0.566 - 0.566 |
52-Week Range | 0.500 - 1.250 |
Beta | -1.86 |
Analysts | n/a |
Price Target | n/a |
Earnings Date | Dec 27, 2024 |
About Novacyt
Novacyt S.A., together with its subsidiaries, provides in vitro and molecular diagnostic tests for a range of infectious diseases in the United Kingdom, rest of Europe, France, the United States, the Asia Pacific, the Middle East, and Africa. It operates through Primer Design, and Yourgene Health segments. The Primer Design segment designs, manufactures, and markets molecular real-time qPCR testing devices and reagents in the areas of infectious diseases. The Yourgene Health segment delivers molecular diagnostic and screening solutions, across ... [Read more]
Financial Performance
In 2023, Novacyt's revenue was 11.58 million, a decrease of -44.97% compared to the previous year's 21.04 million. Losses were -28.29 million, 9.96% more than in 2022.
Financial numbers in GBP Financial StatementsNews
Novacyt SA (NVYTF) Q2 2024 Earnings Call Transcript Highlights: Key Financial Metrics and ...
Novacyt SA (NVYTF) Q2 2024 Earnings Call Transcript Highlights: Key Financial Metrics and Strategic Insights
Half Year 2024 Novacyt SA Earnings Call Transcript
Half Year 2024 Novacyt SA Earnings Call Transcript
Novacyt S.A. (NVYTF) Q2 2024 Earnings Call Transcript
Novacyt S.A. (NVYTF) Q4 2023 Earnings Call Transcript
Novacyt S.A. (OTCPK:NVYTF) Q4 2023 Earnings Conference Call May 30, 2024 6:00 AM ET Company Participants Lyn Rees - CEO Steve Gibson - CFO Conference Call Participants Operator [abrupt start] and welc...
Novacyt S.A. (NVYTF) Q2 2023 Earnings Call Transcript
Novacyt S.A. (OTC:NVYTF) Q2 2023 Earnings Conference Call September 28, 2023 7:30 AM ET Company Participants James McCarthy - Acting CEO Steve Gibson - Group Finance Director Lyn Rees - Executive Dire...
Novacyt S.A. (NVYTF) Q4 2022 Earnings Call Transcript
Novacyt S.A. (OTCPK:NVYTF) Q4 2022 Results Conference Call April 27, 2023 7:00 AM ET Company Participants James McCarthy - Acting Chief Executive Officer Steve Gibson - Group Finance Director Operator...
Novacyt S.A. (NVYTF) Q2 2022 Earnings Call Transcript
Novacyt S.A. (OTCPK:NVYTF) Q2 2022 Earnings Conference Call September 29, 2022 7:00 AM ET Company Participants David Allmond - Chief Executive Officer James McCarthy - Chief Financial Officer Conferen...
Novacyt S.A. ("Novacyt", the "Company" or the "Group"): Half Year 2022 Results
PARIS & CAMBERLEY, England--(BUSINESS WIRE)--Regulatory News: Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces its unaudited results for the ...